ShanX Medtech
Last verified 2026-05-23. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $15.0Mattributed |
|---|---|
| Latest round | seed, $16.2M, 2026-03-01attributed |
| Founded | 2019 |
| Headquarters | Eindhoven, Netherlands |
| Industry | healthtech |
| Stage | seed |
| Website | shanx.nl |
ShanX Medtech develops in-vitro diagnostics for ultra-fast antimicrobial susceptibility testing to fight antibiotic resistance. It serves clinicians who need to pick the right antibiotic quickly. Its FLORA chemistry reads pathogen metabolism in real time, delivering results within about an hour.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-03-01 | seed | $16.2M | undisclosed |
Provenance
| Fact | Status | Basis |
|---|---|---|
| Seed, $16.2M | attributed | rss-feeds named as publisher. No document URL on file. |
| Total raised $15.0M | attributed | rss-feeds named as publisher. No document URL on file. |
| Company existence | self-reported | shanx.nl, read 2026-05-23 |
| Description | self-reported | shanx.nl, read 2026-05-23 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.